방사선 치료, 방사성 의약품, 핵의학 시장

The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.

The global market for radiopharmaceuticals is expected to grow from $9.9 billion in 2024 and is projected to reach $21.0 billion by the end of 2029, at a CAGR of 16.2% during the forecast period of 2024 to 2029.

The global market for radiation therapy products and services is expected to grow from $7.5 billion in 2024 and is projected to reach $10.2 billion by the end of 2029, at a CAGR of 6.3% during the forecast period of 2024 to 2029.

Report Scope

This report analyzes the global market for radiation therapy products (systems, software and services) and radiopharmaceuticals, in terms of quantitative and qualitative data, to help readers develop assess the market, business/growth strategies, and make informed business decisions regarding radiation therapy products and services and radiopharmaceuticals. BCC Research estimates market data for 2023 (the base year) and forecasts values for 2024 through 2029.

Radiation therapy market segmentation is based on product, technology, techniques, system type, application and region. Radiopharmaceuticals market segmentation is based on product, application, production method and region.

Industry growth drivers, restraints and opportunities in the radiation therapy and radiopharmaceutical market are also discussed. The report also reports on the competitive landscape of radiation therapy products, radiopharmaceutical markets and emerging trends. The latest new products, acquisitions, and collaborations related to the radiation therapy and radiopharmaceutical markets are also covered.

Report Includes

• 51 data tables and 39 additional tables
• An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
• Analysis of global market trends, featuring historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2025, and projected CAGRs through 2029
• Identification of new opportunities, challenges and technological changes in the industry and a market share analysis by segment, product type, technology type, application, production method, and region
• Examination of the present and future strategies of companies in the market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
• Discussion of the applications for positron emission tomography (PET) and single photon emission computed tomography (SPECT)
• Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
• Analysis of the current market trends and forecast, R&D activity, product launches and regulatory elements
• Analysis of the key companies' market shares, mergers & acquisitions, joint ventures and collaborations
• Profiles of the major players in the market, including Accuray Inc., Cardinal Health, Elekta, Novartis AG, and Siemens Healthineers AG

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Radiopharmaceuticals
• Radiation Therapy

Chapter 3 Market Dynamics

• Radiotherapy Market Drivers
• Rising Prevalence of Cancer
• Early Screening
• Advances in Radiation Therapy Planning and Delivery Systems
• Increasing Demand in Developing Regions
• Applications Beyond Oncology
• Radiotherapy Market Restraints
• Shortage of Skilled Professionals
• Limited Effectiveness against Metastatic Cancer
• Trends in Radiotherapy Market
• Growing Use of Advanced Imaging and Hypofractionation
• Adaptive Radiation Therapy
• Radiopharmaceutical Market Drivers
• Rising Prevalence of Chronic Diseases
• Focus on Early Diagnosis and Screening
• Precision Medicine
• Nuclear Imaging Technologies
• Increasing Investments
• Radiopharmaceutical Market Restraints
• Manufacturing and Supply Chain Issues
• Infrastructure and Specialized Imaging Equipment Requirements
• Trends in the Radiopharmaceutical Market
• Theranostics
• PET/MRI Hybrid Imaging

Chapter 4 Emerging Technologies and Developments

• Emerging Technologies in Radiation Therapy
• Artificial Intelligence
• Online Adaptive Radiation Therapy
• MR-Linac
• FLASH Radiation Therapy
• Emerging Technologies in Radiopharmaceuticals
• Targeted Alpha Therapy

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Radiation Therapy Market, by Product Type
• Market Overview
• Market Size and Forecast
• Radiation Therapy Market, by Technology Type
• Market Size and Forecast
• External Beam Radiation Therapy
• EBRT by Technique Type
• EBRT, by System Type
• EBRT, by Application
• Internal Beam Radiation Therapy
• IBRT, by Technique Type
• IBRT, by Product Type
• IBRT, by Application
• Radiation Therapy Market, by Region
• Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of the World (Row)
• Radiopharmaceuticals Market, by Product Type
• Market Size and Forecast
• Diagnostic Radiopharmaceuticals
• Therapeutic Radiopharmaceuticals
• Radiopharmaceuticals Market, by Application
• Market Size and Forecast
• Oncology
• Cardiology
• Neurology
• Other Applications
• Radiopharmaceuticals Market, by Production Method
• Market Overview
• Nuclear Reactors
• Cyclotrons
• Radionuclide Generators
• Market Size and Forecast
• Geographic Breakdown
• Radiopharmaceuticals Market, by Region
• Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• RoW

Chapter 6 Competitive Intelligence

• Leading Radiotherapy Device Manufacturers
• Leading Companies in Radiopharmaceuticals

Chapter 7 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ACCURAY INC.
• CARDINAL HEALTH
• CURIUM
• ELEKTA
• GE HEALTHCARE
• LANTHEUS
• NOVARTIS AG
• SIEMENS HEATHNIEERS AG